NCT00065065 - A Trial of Rosiglitazone for Ulcerative Colitis | Biotech Hunter

Enrollment

105

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions

Ulcerative ColitisInflammatory Bowel Disease

Interventions

DRUG

Rosiglitazone

4mg orally twice daily for 12 weeks

DRUG

Placebo

pill that looks identical to rosiglitazone

Trial Locations (13)

University of Pennsylvania - Presbyterian Medical Center, Philadelphia

Maryland Digestive Diseases Research, Laurel

Metropolitan Gastroenterology Group Practice/Chevy Chase Clinical Research, Chevy Chase

Capitol Gastroenterology Consultants, Silver Spring

Wake Research Associates, Raleigh

Atlanta Gastroenterology Associates, Atlanta

University Hospitals of Cleveland, Cleveland

The Cleveland Clinic Foundation, Cleveland

Avamar Center for Endoscopy, Warren

Minnesota Gastroenterology, Plymouth

University of Chicago Hospitals, Chicago

Massachusetts General Hospital, Boston

Atlantic Gastroenterology Associates, Egg Harbor